Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Q3 2025 value amounting to 0.92.

  • Ironwood Pharmaceuticals' Asset Utilization Ratio fell 482.81% to 0.92 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.92, marking a year-over-year decrease of 482.81%. This contributed to the annual value of 0.86 for FY2024, which is 5175.68% up from last year.
  • Ironwood Pharmaceuticals' Asset Utilization Ratio amounted to 0.92 in Q3 2025, which was down 482.81% from 0.92 recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Asset Utilization Ratio's 5-year high stood at 0.96 during Q3 2024, with a 5-year trough of 0.37 in Q1 2023.
  • In the last 5 years, Ironwood Pharmaceuticals' Asset Utilization Ratio had a median value of 0.69 in 2021 and averaged 0.66.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Asset Utilization Ratio tumbled by 5355.77% in 2021 and then soared by 14579.31% in 2024.
  • Over the past 5 years, Ironwood Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.38 in 2021, then increased by 2.27% to 0.38 in 2022, then soared by 131.97% to 0.89 in 2023, then grew by 6.68% to 0.95 in 2024, then dropped by 3.35% to 0.92 in 2025.
  • Its Asset Utilization Ratio stands at 0.92 for Q3 2025, versus 0.92 for Q2 2025 and 0.94 for Q1 2025.